{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_002904.3:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_002904.3",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K mutation increases fibrillization propensity"
        },
        {
          "HGVS": "NM_002904.3:c.137G>C",
          "cDNA Change": {
            "transcript": "NM_002904.3",
            "ref": "G",
            "alt": "C",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "A",
            "position": "46"
          },
          "Description in input context": "E46A mutation alters aggregation properties"
        },
        {
          "HGVS": "NM_002904.3:c.248A>G",
          "cDNA Change": {
            "transcript": "NM_002904.3",
            "ref": "A",
            "alt": "G",
            "position": "248"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "83"
          },
          "Description in input context": "E83K mutation affects amyloid formation"
        },
        {
          "HGVS": "NM_002904.3:c.248A>T",
          "cDNA Change": {
            "transcript": "NM_002904.3",
            "ref": "A",
            "alt": "T",
            "position": "248"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "A",
            "position": "83"
          },
          "Description in input context": "E83A mutation reduces fibril stability"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004986"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro fibrillization assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Wild-type and mutant α-synuclein variants",
        "Description": "Wild-type and mutant α-synuclein proteins were expressed in E. coli and purified for aggregation studies."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_002904.3:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased fibrillization rate",
          "Result Description": "E46K showed accelerated ThT fluorescence increase compared to wild-type, indicating enhanced aggregation."
        },
        {
          "Variant": "NM_002904.3:c.137G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered aggregation kinetics",
          "Result Description": "E46A exhibited distinct ThT fluorescence patterns with delayed fibril formation."
        },
        {
          "Variant": "NM_002904.3:c.248A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced amyloid formation",
          "Result Description": "E83K demonstrated higher ThT fluorescence intensity at 24 hours compared to wild-type."
        },
        {
          "Variant": "NM_002904.3:c.248A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced fibril stability",
          "Result Description": "E83A showed decreased ThT fluorescence intensity with increased lag phase duration."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each biological replicate was measured in triplicate using a plate reader."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control for aggregation."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Bovine serum albumin (BSA) was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey test for multiple comparisons."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ThT fluorescence intensity within ±20% of wild-type at 48 hours.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ThT fluorescence intensity deviating by >20% from wild-type at 48 hours.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}